In the current study, almost all patients with perineural invasion had KRAS mutations, suggesting that KRAS mutation status can predict tumour growth and progression as well as recurrence, though we did not find any correlation between KRAS status and disease recurrence. The gene discussed is KRAS; the disease is neoplasm.